Information flows in the human brain. Roger Guillemin is 100 years old

Cover Page

Cite item

Full Text

Abstract

The paper presents brief biographical information for the 100th anniversary of Roger Guillemin, a distinguished American scientist who won the 1977 Nobel Prize in Physiology or Medicine. He shared half of the prize with Andrew W. Schally “for their discoveries concerning the peptide hormone production of the brain”; the other half went to Rosalyn S. Yalow “for the development of radioimmunoassays of peptide hormones”. The paper briefly describes the main scientific achievements of R. Guillemin in the development of neuroendocrinology. He isolated somatotropin (growth hormone), identified molecules of thyrotropin-releasing hormone thyreoliberin, which controls all thyroid functions, as well as dozens of other molecules from the hypothalamus. His research has led to the development of treatments for diseases ranging from infertility to pituitary tumors. With his discoveries of certain information flows in the human brain, he contributed to deciphering the code of human life. Guillemin's early training in the construction of radio receivers and transmitters was of great importance, and his serious experience with computers has led him to become one of the pioneers in digital painting. R. Guillemin retired from active scientific life only three years ago.

Full Text

In Nobel studies, there are several cases where Nobel laureates lived to see their centenary, with almost all of them occurring in the 21st century, and one of the reasons for the increase in creative longevity is the activities of the laureates themselves, including the 1977 Nobel Prize in Physiology or Medicine laureate Roger Guillemin (Fig. 1). He shared half the prize with Andrew W. Schally “for his discoveries concerning the production of peptide hormones in the brain”, and the other half went to Rosalyn Yallow “for the development of a radioimmunoassay for peptide hormones”. The results of their research have made a significant contribution to increasing human life expectancy.

 

Fig. 1. R. Guillemin at the age of 90

 

Roger Guillemin [1, 2] was born on January 11, 1924 in the city of Dijon, the capital of Burgundy (France). Despite the occupation of Dijon by the Germans from 1940 to 1944, he managed to graduate from primary school and lyceum, receive a medical education and, in 1949, a doctorate in endocrinology. Having met Hans Selye, Guillemin received a scholarship from his foundation and moved to the Institute of Experimental Medicine and Surgery at the University of Montreal (Canada). It was there that he completed his doctoral research, and in 1953 he earned his PhD in physiology. Then he moved to the USA, until 1970 he taught at Baylor College of Medicine in Houston (Texas), moved to the Salk Institute for Biological Research in San Diego (California), where he founded the world's first laboratory of neuroendocrinology, developed his main discoveries and is still listed as an emeritus professor [3]. There he celebrated his 100th birthday (Fig. 2). R. Guillemin is the generally recognized founder of neuroendocrinology, a study of the interaction of the endocrine and nervous systems, i.e. regulation by the brain of the body’s hormonal activity. His research into brain hormones led to the development of treatments for diseases ranging from infertility to pituitary tumors. In fierce competition with a native of Poland, E.V. Schally (“Many years of aggression and cruel revenge” [4, 5]), which is even called the “third neuroscientific war” [4], R. Guillemin managed to discover somatostinum, a regulator of the functioning of the pituitary gland and pancreas, isolate endorphins - brain molecules that act as opium alkaloids, identify cellular growth factors, discover the role of the brain in regulating hormones – molecules that act as chemical messengers between different parts of the body and regulate body functions.

 

Fig. 2. R. Guillemin at the celebration of his 100th birthday

 

These studies were incredibly painstaking and lengthy, without much hope of success. Suffice it to say that in four years (1964-1967) in Houston, more than 5 million pieces (50 tons) of sheep hypothalamus had to be collected, and the purification and determination of the chemicalstructure of the first neurohormone thyrotropin-releasing factor (TRF) took seven years and was successfully completed in 1969 Subsequently, R. Guillemin calculated that 1 kg of purified TRF cost 2.5 times more than the same weight of soil delivered from the Moon. This success led to the isolation of somatotropin (growth hormone), the identification of the thyrotropin-releasing hormone (TRH) molecule, thyrotropin-releasing hormone, which controls all functions of the thyroid gland. The use of the radioimmunoassay method developed by R. Yalow played a huge role in further work. Later, R. Guillemin and E. Schally (both received American citizenship in the 1960s) and their colleagues isolated other molecules from the hypothalamus (now many dozens of them are known) that control all functions of the pituitary gland, for example, gonadotropin-releasing hormone (GnRH) – A hormone from the hypothalamus that causes the pituitary gland to release gonadotropins, causing the release of hormones from the testes or ovaries. This discovery led to advances in the treatment of infertility and prostate cancer. It became clear that the human brain is the most important gland of the body.

Thus, R. Guillemin joined a small circle of outstanding scientists, each of whom, with their discoveries of individual information flows in the human brain [6], contributed to deciphering the code of human life (Fig. 3).

 

Fig. 3. Four Nobel Prize laureates in physiology or medicine (from left to right; years of award in brackets) at one conference: R. Dulbecco (1975), R. Guillemin (1977), R. Holley (1968) and F. Crick (1962)

 

R. Guillemin was an amazingly versatile personality. Even in childhood and adolescence, he persistently developed not only his brain, but also his hands, creating, for example, radio receivers and transmitters. In his mature years, he transferred his many years of experience with computers from neuroendocrinology to art and became one of the pioneers in digital painting; he is also known as an avid collector of French and American paintings and sculptures, Papuan and pre-Columbian ceramics. Several keyboards and stringed instruments form part of the pleasant furnishings of his happy home. Having retired from active scientific work, R. Guillemin spent the last three years in Del Mar (California) and devoted all his time to his family. He had five daughters, a son, four grandchildren and two great-grandchildren. His wife Lucienne, to whom he was married for 69 years, died in 2021 at the age of 100!

At the centennial celebration, the current president of the Salk Institute, Gerald Joyce, said: “Roget is one of the world's greatest minds and at the same time one of the kindest people you will ever meet” [3].

Unfortunately, when the article was already in print, the sad news came about the death of Roger Guillemin on February 21, 2024.

Funding

This study received no external funding.

Conflict of interests

The authors declare no conflict of interest.

×

About the authors

Viacheslav M. Tyutyunnik

Tambov State Technical University; International Nobel Information Centre (INIC)

Author for correspondence.
Email: vmtyutyunnik@gmail.com
ORCID iD: 0000-0003-2099-5730

D. Sc. (Eng.), Professor; General Director

Russian Federation, Tambov; Tambov

References

  1. Klavdiyeva MM. To the centenary of Nobel laureate Roger Guillemin. Guillemin and his influence on Soviet neuroendocrinologists. Istoriko-biologicheskiye issledovaniya. 2023;4:96-121. doi: 10.24412/2076-8176-2023-4-96-121 (In Russ.)
  2. Karyakin OB. Roger Guillemin, Andrew Victor Schally, Rosalyn Sassman Yalow. Cancer Urology. 2021;4:176-180. doi: 10.17650/1726-9776-2021-17-4-176-180 (In Russ.)
  3. Roger Guillemin. Available from: https://www.salk.edu/ru/news-release/salk-distinguished-professor-emeritus-roger-guillemin-nobel-prize-laureate-celebrates-100th-birthday/ [Accessed 11 January 2024].
  4. Paevsky A. Nobel laureates: Roger Guillemin. The third neuroscientific war. Available from: https://indicator.ru/medicine/nobelevskie-laureaty-rozhe-giimen.htm [Accessed 11 January 2024] (In Russ.)
  5. Sapolsky R. Why zebras don't have heart attacks: The Psychology of Stress. St. Petersburg: Piter; 2019. 700 p. (In Russ.)
  6. Fedorov VA, Hargittai I, Tyutyunnik VM. The Global information and cosmological problem: 2020 Nobel Prize Winner in Physics Roger Penrose. Journal of Advanced Materials and Technologies. 2022;3:168-171. doi: 10.17277/jamt.2022.03.pp.168-171

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. R. Guillemin at the age of 90

Download (115KB)
3. Fig. 2. R. Guillemin at the celebration of his 100th birthday

Download (75KB)
4. Fig. 3. Four Nobel Prize laureates in physiology or medicine (from left to right; years of award in brackets) at one conference: R. Dulbecco (1975), R. Guillemin (1977), R. Holley (1968) and F. Crick (1962)

Download (171KB)


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».